J. Ziello
Cancer Research · 2007
A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Cancer Research — 8 citations into it
Whom J. Ziello trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from J. Ziello's perspective
Ordered by how strongly the researchers J. Ziello trusts endorse each paper. Same corpus, a different order for every researcher.
- HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. (Cell Metabolism)
- Asparagine Hydroxylation of the HIF Transactivation Domain: A Hypoxic Switch (Science)
- HIF-1: mediator of physiological and pathophysiological responses to hypoxia. (Journal of applied physiology)
- HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity. (Cancer Cell)
- C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. (Cell)
- Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1alpha in vascular smooth muscle cells. (Journal of Biological Chemistry)
- The role of hypoxia-induced factors in tumor progression. (The Oncologist)
- Differential Function of the Prolyl Hydroxylases PHD1, PHD2, and PHD3 in the Regulation of Hypoxia-inducible Factor* (Journal of Biological Chemistry)
- Targeting of HIF-α to the von Hippel-Lindau Ubiquitylation Complex by O2-Regulated Prolyl Hydroxylation (Science)
- Why do cancers have high aerobic glycolysis? (Nature Reviews. Cancer)